Now:HOME > ACADEMIC CONFERENCE >Academic trends
The Rare Disease Professional Committee of Chengdu High tech Medical Association successfully held its 2025 academic conference on the rare diseases of the rare diseases in the rare and prosperous city of Shu, showcasing the great achievements of frost mo
Author:质控  Addtime:2025-11-29

To deepen the exploration and exchange of rare diseases, and to light up the hope of diagnosis and treatment with innovative wisdom; To promote the advancement of diagnosis and treatment technology and build a rehabilitation pathway with the power of technology. The "Rare Disease Professional Committee 2025 Academic Conference and Sichuan Province Continuing Medical Education Project" Children's Blood Disease Diagnosis and Treatment Standards Learning Class "jointly organized by Chengdu High tech Medical Association and Chengdu Women and Children's Center Hospital, and undertaken by the Rare Disease Special Committee, Thrombosis and Hemostasis Group of the Rare Disease Special Committee, and Children's Hereditary Cardiovascular Disease Group of the Chengdu High tech Medical Association, was successfully held in Chengdu on November 29, 2025.

image.png 

The opening ceremony was presided over by Professor Zhou Min, the incoming chairman of the Rare Disease Professional Committee of Chengdu High tech Medical Association. Vice President Lin Yan of Chengdu Women and Children's Center Hospital and Vice President and Deputy Secretary General Ai He of Chengdu High tech Medical Association attended the meeting and delivered speeches. Their speeches shone like brilliant lights, piercing through the dense fog of rare disease research and outlining a clear path in the vast academic sky, leading the attendees to move forward with determination.
Guest Speaker

image.png

Vice Dean Lin Yan

Chengdu Women and Children's Center Hospital

image.png 

Vice President and Deputy Secretary General of Aihe

Chengdu High tech Medical Association

Opening Ceremony Host

image.png 

Professor Zhou Min

Chairman elect of the Rare Disease Special Committee of Chengdu High tech Medical Association

            At the beginning of the meeting, Professor Li Xiaojing, Chairman of the Rare Disease Professional Committee of Chengdu High tech Medical Association, brought everyone a summary report of the committee's work in 2025. She counted the numerous achievements of the special committee in rare disease research and gained insight into the current challenges and opportunities. Under her guidance, the members worked together to create a brilliant chapter in rare disease research.

image.png 

Professor Li Xiaojing

Chairman of the Rare Disease Special Committee of Chengdu High tech Medical Association

 

Subsequently, the academic conference kicked off with warm applause. The conference venue is like a shining knowledge temple, attracting medical elites from all over the world to gather. Experts and scholars, like a beacon of wisdom, illuminate the unknown waters of children's blood disease diagnosis and treatment. With profound knowledge and rich experience, they analyze the key points of diseases from common disease standardized diagnosis and treatment to rare disease precise treatment, from cutting-edge technology exploration to multidisciplinary collaboration. The topics are closely related to the times, and the explanations are fascinating. The atmosphere during the discussion session was as lively as a feast for thought, with everyone actively interacting and colliding to create sparks of wisdom.

Guest lecturer

image.png 

Professor Lang Xiaoling

West China Second Hospital of Sichuan University

image.png 

Professor Hua Yimin

West China Second Hospital of Sichuan University

image.png 

Professor Zhou Min

Chengdu Women and Children's Center Hospital


       This grand event is a collision of academic knowledge, a fusion of wisdom, and also a baptism of the soul, elevating the spirit. The Rare Disease Professional Committee of Chengdu High tech Medical Association will continue to uphold the concept of "innovation, collaboration, and sharing", work together with colleagues to embark on the profound journey of rare disease research, and bring hope and brightness to more rare disease patients.